Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis

Abstract Background Protein palmitoylation, which is catalyzed by palmitoyl-transferase and de-palmitoyl-transferase, plays a crucial role in various biological processes. However, the landscape and dynamics of protein palmitoylation in human cancers are not well understood. Methods We utilized 23 p...

Full description

Bibliographic Details
Main Authors: Yue Kong, Yugeng Liu, Xianzhe Li, Menglan Rao, Dawei Li, Xiaolan Ruan, Shanglin Li, Zhenyou Jiang, Qiang Zhang
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-023-04611-8
_version_ 1797556851268648960
author Yue Kong
Yugeng Liu
Xianzhe Li
Menglan Rao
Dawei Li
Xiaolan Ruan
Shanglin Li
Zhenyou Jiang
Qiang Zhang
author_facet Yue Kong
Yugeng Liu
Xianzhe Li
Menglan Rao
Dawei Li
Xiaolan Ruan
Shanglin Li
Zhenyou Jiang
Qiang Zhang
author_sort Yue Kong
collection DOAJ
description Abstract Background Protein palmitoylation, which is catalyzed by palmitoyl-transferase and de-palmitoyl-transferase, plays a crucial role in various biological processes. However, the landscape and dynamics of protein palmitoylation in human cancers are not well understood. Methods We utilized 23 palmitoyl-acyltransferases and seven de-palmitoyl-acyltransferases as palmitoylation-related genes for protein palmitoylation analysis. Multiple publicly available datasets were employed to conduct pan-cancer analysis, examining the transcriptome, genomic alterations, clinical outcomes, and correlation with c-Myc (Myc) for palmitoylation-related genes. Real-time quantitative PCR and immunoblotting were performed to assess the expression of palmitoylation-related genes and global protein palmitoylation levels in cancer cells treated with Myc depletion or small molecule inhibitors. Protein docking and drug sensitivity analyses were employed to predict small molecules that target palmitoylation-related genes. Results We identified associations between palmitoylation and cancer subtype, stage, and patient survival. We discovered that abnormal DNA methylation and oncogenic Myc-driven transcriptional regulation synergistically contribute to the dysregulation of palmitoylation-related genes. This dysregulation of palmitoylation was closely correlated with immune infiltration in the tumor microenvironment and the response to immunotherapy. Importantly, dysregulated palmitoylation was found to modulate canonical cancer-related pathways, thus influencing tumorigenesis. To support our findings, we performed a proof-of-concept experiment showing that depletion of Myc led to reduced expression of most palmitoylation-related genes, resulting in decreased global protein palmitoylation levels. Through mass spectrometry and enrichment analyses, we also identified palmitoyl-acyltransferases ZDHHC7 and ZDHHC23 as significant contributors to mTOR signaling, DNA repair, and immune pathways, highlighting their potential roles in tumorigenesis. Additionally, our study explored the potential of three small molecular (BI-2531, etoposide, and piperlongumine) to modulate palmitoylation by targeting the expression or activity of palmitoylation-related genes or enzymes. Conclusions Overall, our findings underscore the critical role of dysregulated palmitoylation in tumorigenesis and the response to immunotherapy, mediated through classical cancer-related pathways and immune cell infiltration. Additionally, we propose that the aforementioned three small molecule hold promise as potential therapeutics for modulating palmitoylation, thereby offering novel avenues for cancer therapy.
first_indexed 2024-03-10T17:08:48Z
format Article
id doaj.art-6f6591be4c3846eea1b992dfb142bc64
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-03-10T17:08:48Z
publishDate 2023-11-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-6f6591be4c3846eea1b992dfb142bc642023-11-20T10:43:48ZengBMCJournal of Translational Medicine1479-58762023-11-0121111910.1186/s12967-023-04611-8Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesisYue Kong0Yugeng Liu1Xianzhe Li2Menglan Rao3Dawei Li4Xiaolan Ruan5Shanglin Li6Zhenyou Jiang7Qiang Zhang8Department of Microbiology and Immunology, Basic Medicine College, Jinan UniversityShenzhen Branch, Guangdong Laboratory of Lingnan Modern Agriculture, Genome Analysis Laboratory of the Ministry of Agriculture, Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural SciencesDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ)Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan UniversityZhumadian Central Hospital, Huanghuai UniversityGuangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan UniversityDepartment of Microbiology and Immunology, Basic Medicine College, Jinan UniversityDepartment of Microbiology and Immunology, Basic Medicine College, Jinan UniversityMolecular Cancer Research Center, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen UniversityAbstract Background Protein palmitoylation, which is catalyzed by palmitoyl-transferase and de-palmitoyl-transferase, plays a crucial role in various biological processes. However, the landscape and dynamics of protein palmitoylation in human cancers are not well understood. Methods We utilized 23 palmitoyl-acyltransferases and seven de-palmitoyl-acyltransferases as palmitoylation-related genes for protein palmitoylation analysis. Multiple publicly available datasets were employed to conduct pan-cancer analysis, examining the transcriptome, genomic alterations, clinical outcomes, and correlation with c-Myc (Myc) for palmitoylation-related genes. Real-time quantitative PCR and immunoblotting were performed to assess the expression of palmitoylation-related genes and global protein palmitoylation levels in cancer cells treated with Myc depletion or small molecule inhibitors. Protein docking and drug sensitivity analyses were employed to predict small molecules that target palmitoylation-related genes. Results We identified associations between palmitoylation and cancer subtype, stage, and patient survival. We discovered that abnormal DNA methylation and oncogenic Myc-driven transcriptional regulation synergistically contribute to the dysregulation of palmitoylation-related genes. This dysregulation of palmitoylation was closely correlated with immune infiltration in the tumor microenvironment and the response to immunotherapy. Importantly, dysregulated palmitoylation was found to modulate canonical cancer-related pathways, thus influencing tumorigenesis. To support our findings, we performed a proof-of-concept experiment showing that depletion of Myc led to reduced expression of most palmitoylation-related genes, resulting in decreased global protein palmitoylation levels. Through mass spectrometry and enrichment analyses, we also identified palmitoyl-acyltransferases ZDHHC7 and ZDHHC23 as significant contributors to mTOR signaling, DNA repair, and immune pathways, highlighting their potential roles in tumorigenesis. Additionally, our study explored the potential of three small molecular (BI-2531, etoposide, and piperlongumine) to modulate palmitoylation by targeting the expression or activity of palmitoylation-related genes or enzymes. Conclusions Overall, our findings underscore the critical role of dysregulated palmitoylation in tumorigenesis and the response to immunotherapy, mediated through classical cancer-related pathways and immune cell infiltration. Additionally, we propose that the aforementioned three small molecule hold promise as potential therapeutics for modulating palmitoylation, thereby offering novel avenues for cancer therapy.https://doi.org/10.1186/s12967-023-04611-8PalmitoylationCancerDNA methylationc-MycImmunotherapySmall molecular
spellingShingle Yue Kong
Yugeng Liu
Xianzhe Li
Menglan Rao
Dawei Li
Xiaolan Ruan
Shanglin Li
Zhenyou Jiang
Qiang Zhang
Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis
Journal of Translational Medicine
Palmitoylation
Cancer
DNA methylation
c-Myc
Immunotherapy
Small molecular
title Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis
title_full Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis
title_fullStr Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis
title_full_unstemmed Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis
title_short Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis
title_sort palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis
topic Palmitoylation
Cancer
DNA methylation
c-Myc
Immunotherapy
Small molecular
url https://doi.org/10.1186/s12967-023-04611-8
work_keys_str_mv AT yuekong palmitoylationlandscapesacrosshumancancersrevealaroleofpalmitoylationintumorigenesis
AT yugengliu palmitoylationlandscapesacrosshumancancersrevealaroleofpalmitoylationintumorigenesis
AT xianzheli palmitoylationlandscapesacrosshumancancersrevealaroleofpalmitoylationintumorigenesis
AT menglanrao palmitoylationlandscapesacrosshumancancersrevealaroleofpalmitoylationintumorigenesis
AT daweili palmitoylationlandscapesacrosshumancancersrevealaroleofpalmitoylationintumorigenesis
AT xiaolanruan palmitoylationlandscapesacrosshumancancersrevealaroleofpalmitoylationintumorigenesis
AT shanglinli palmitoylationlandscapesacrosshumancancersrevealaroleofpalmitoylationintumorigenesis
AT zhenyoujiang palmitoylationlandscapesacrosshumancancersrevealaroleofpalmitoylationintumorigenesis
AT qiangzhang palmitoylationlandscapesacrosshumancancersrevealaroleofpalmitoylationintumorigenesis